US$ 23.09
intravenous glutathione parkinson's disease randomized trial Frontiers Revamping Parkinson's disease therapy using
Description
Journal of Critical Care

Ngamma-aryl glutamine analogues as probes of the Asct2 neutral amino acid transporter binding site

Mora, A., Komander, D., van Aalten, D

India:Springer (2017)

3 TNF production by the patients primary cells
